デフォルト表紙
市場調査レポート
商品コード
1120363

世界の消化器治療薬市場:考察と予測 (2028年まで)

Global Gastrointestinal Therapeutics Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 110 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
世界の消化器治療薬市場:考察と予測 (2028年まで)
出版日: 2022年08月30日
発行: QYResearch
ページ情報: 英文 110 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、消化器治療薬 (Gastrointestinal Therapeutics) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界の消化器治療薬の市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Oral
    • Parenteral
  • 市場:アプリケーション別
    • 世界の消化器治療薬の市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • IBD
    • Irritable Bowel Syndrome (IBS)
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の消化器治療薬の市場展望 (2017-2028)
  • 消化器治療薬の市場成長トレンド:地域別
    • 消化器治療薬 市場規模:地域別: 2017 VS 2021 VS 2028
    • 消化器治療薬の市場規模実績:地域別 (2017-2022)
    • 消化器治療薬の市場規模予測:地域別 (2023-2028)
  • 消化器治療薬 市場動向
    • 消化器治療薬 業界動向
    • 消化器治療薬 市場の促進要因
    • 消化器治療薬 市場の課題
    • 消化器治療薬 市場の抑制要因

第3章 競合情勢:主要企業別

  • 世界の消化器治療薬の上位企業:収益別
    • 世界の消化器治療薬の上位企業:収益別 (2017-2022)
    • 世界の消化器治療薬の収益シェア:企業別 (2017-2022)
  • 世界の消化器治療薬の市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 企業ランキング:消化器治療薬の収益
  • 世界の消化器治療薬 市場集中度
    • 世界の消化器治療薬 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業: 消化器治療薬の収益 2021
  • 消化器治療薬の主要企業の本社および事業エリア
  • 主要企業 消化器治療薬の製品ソリューションおよびサービス
  • 市場参入時期: 消化器治療薬 市場
  • M&A, 拡張計画

第4章 消化器治療薬 内訳データ:タイプ別

  • 世界の消化器治療薬の市場規模実績:タイプ別 (2017-2022)
  • 世界の消化器治療薬の市場規模予測:タイプ別 (2023-2028)

第5章 消化器治療薬 内訳データ:アプリケーション別

  • 世界の消化器治療薬の市場規模実績:アプリケーション別 (2017-2022)
  • 世界の消化器治療薬の市場規模予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米の消化器治療薬 市場規模 (2017-2028)
  • 北米の消化器治療薬 市場規模:タイプ別
    • 北米の消化器治療薬 市場規模:タイプ別 (2017-2022)
    • 北米の消化器治療薬 市場規模:タイプ別 (2023-2028)
    • 北米の消化器治療薬の市場シェア:タイプ別 (2017-2028)
  • 北米の消化器治療薬 市場規模:アプリケーション別
    • 北米の消化器治療薬 市場規模:アプリケーション別 (2017-2022)
    • 北米の消化器治療薬 市場規模:アプリケーション別 (2023-2028)
    • 北米の消化器治療薬の市場シェア:アプリケーション別 (2017-2028)
  • 北米の消化器治療薬 市場規模:国別
    • 北米の消化器治療薬 市場規模:国別 (2017-2022)
    • 北米の消化器治療薬 市場規模:国別 (2023-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の消化器治療薬 市場規模 (2017-2028)
  • 欧州の消化器治療薬 市場規模:タイプ別
    • 欧州の消化器治療薬 市場規模:タイプ別 (2017-2022)
    • 欧州の消化器治療薬 市場規模:タイプ別 (2023-2028)
    • 欧州の消化器治療薬の市場シェア:タイプ別 (2017-2028)
  • 欧州の消化器治療薬 市場規模:アプリケーション別
    • 欧州の消化器治療薬 市場規模:アプリケーション別 (2017-2022)
    • 欧州の消化器治療薬 市場規模:アプリケーション別 (2023-2028)
    • 欧州の消化器治療薬の市場シェア:アプリケーション別 (2017-2028)
  • 欧州の消化器治療薬 市場規模:国別
    • 欧州の消化器治療薬 市場規模:国別 (2017-2022)
    • 欧州の消化器治療薬 市場規模:国別 (2023-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 アジア太平洋地域

  • アジア太平洋地域 消化器治療薬 市場規模 (2017-2028)
  • アジア太平洋地域 消化器治療薬 市場規模:タイプ別
    • アジア太平洋地域 消化器治療薬 市場規模:タイプ別 (2017-2022)
    • アジア太平洋地域 消化器治療薬 市場規模:タイプ別 (2023-2028)
    • アジア太平洋地域 消化器治療薬の市場シェア:タイプ別 (2017-2028)
  • アジア太平洋地域 消化器治療薬 市場規模:アプリケーション別
    • アジア太平洋地域 消化器治療薬 市場規模:アプリケーション別 (2017-2022)
    • アジア太平洋地域 消化器治療薬 市場規模:アプリケーション別 (2023-2028)
    • アジア太平洋地域 消化器治療薬の市場シェア:アプリケーション別 (2017-2028)
  • アジア太平洋地域 消化器治療薬 市場規模:地域別
    • アジア太平洋地域 消化器治療薬 市場規模:地域別 (2017-2022)
    • アジア太平洋地域 消化器治療薬 市場規模:地域別 (2023-2028)
    • 中国
    • 日本
    • 韓国
    • 東南アジア
    • インド
    • オーストラリア

第9章 ラテンアメリカ

  • ラテンアメリカの消化器治療薬 市場規模 (2017-2028)
  • ラテンアメリカの消化器治療薬 市場規模:タイプ別
    • ラテンアメリカの消化器治療薬 市場規模:タイプ別 (2017-2022)
    • ラテンアメリカの消化器治療薬 市場規模:タイプ別 (2023-2028)
    • ラテンアメリカの消化器治療薬の市場シェア:タイプ別 (2017-2028)
  • ラテンアメリカの消化器治療薬 市場規模:アプリケーション別
    • ラテンアメリカの消化器治療薬 市場規模:アプリケーション別 (2017-2022)
    • ラテンアメリカの消化器治療薬 市場規模:アプリケーション別 (2023-2028)
    • ラテンアメリカの消化器治療薬の市場シェア:アプリケーション別 (2017-2028)
  • ラテンアメリカの消化器治療薬 市場規模:国別
    • ラテンアメリカの消化器治療薬 市場規模:国別 (2017-2022)
    • ラテンアメリカの消化器治療薬 市場規模:国別 (2023-2028)
    • メキシコ
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカの消化器治療薬 市場規模 (2017-2028)
  • 中東・アフリカの消化器治療薬 市場規模:タイプ別
    • 中東・アフリカの消化器治療薬 市場規模:タイプ別 (2017-2022)
    • 中東・アフリカの消化器治療薬 市場規模:タイプ別 (2023-2028)
    • 中東・アフリカの消化器治療薬の市場シェア:タイプ別 (2017-2028)
  • 中東・アフリカの消化器治療薬 市場規模:アプリケーション別
    • 中東・アフリカの消化器治療薬 市場規模:アプリケーション別 (2017-2022)
    • 中東・アフリカの消化器治療薬 市場規模:アプリケーション別 (2023-2028)
    • 中東・アフリカの消化器治療薬の市場シェア:アプリケーション別 (2017-2028)
  • 中東・アフリカの消化器治療薬 市場規模:国別
    • 中東・アフリカの消化器治療薬 市場規模:国別 (2017-2022)
    • 中東・アフリカの消化器治療薬 市場規模:国別 (2023-2028)
    • トルコ
    • サウジアラビア
    • UAE

第11章 主要企業のプロファイル

  • AbbVie
  • Allergan
  • Johnson & Johnson
  • Takeda
  • Novartis
  • Pfizer
  • Merck
  • F. Hoffmann-La Roche
  • Eli Lilly
  • AstraZeneca
  • Procter & Gamble
  • Tillotts Pharma
  • Takeda
  • GlaxoSmithKline
  • Amgen

第12章 アナリストによる分析/結論

第13章 付録

図表
  • Table 1. Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
  • Table 2. Key Players of Oral
  • Table 3. Key Players of Parenteral
  • Table 4. Global Gastrointestinal Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
  • Table 5. Global Gastrointestinal Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global Gastrointestinal Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global Gastrointestinal Therapeutics Market Share by Region (2017-2022)
  • Table 8. Global Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global Gastrointestinal Therapeutics Market Share by Region (2023-2028)
  • Table 10. Gastrointestinal Therapeutics Market Trends
  • Table 11. Gastrointestinal Therapeutics Market Drivers
  • Table 12. Gastrointestinal Therapeutics Market Challenges
  • Table 13. Gastrointestinal Therapeutics Market Restraints
  • Table 14. Global Gastrointestinal Therapeutics Revenue by Players (2017-2022) & (US$ Million)
  • Table 15. Global Gastrointestinal Therapeutics Revenue Share by Players (2017-2022)
  • Table 16. Global Top Gastrointestinal Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021)
  • Table 17. Ranking of Global Top Gastrointestinal Therapeutics Companies by Revenue (US$ Million) in 2021
  • Table 18. Global 5 Largest Players Market Share by Gastrointestinal Therapeutics Revenue (CR5 and HHI) & (2017-2022)
  • Table 19. Key Players Headquarters and Area Served
  • Table 20. Key Players Gastrointestinal Therapeutics Product Solution and Service
  • Table 21. Date of Enter into Gastrointestinal Therapeutics Market
  • Table 22. Mergers & Acquisitions, Expansion Plans
  • Table 23. Global Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 24. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2017-2022)
  • Table 25. Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 26. Global Gastrointestinal Therapeutics Revenue Market Share by Type (2023-2028)
  • Table 27. Global Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 28. Global Gastrointestinal Therapeutics Revenue Share by Application (2017-2022)
  • Table 29. Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 30. Global Gastrointestinal Therapeutics Revenue Share by Application (2023-2028)
  • Table 31. North America Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 32. North America Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 33. North America Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 34. North America Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 35. North America Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 36. North America Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 37. Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 38. Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 39. Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 40. Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 41. Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 42. Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 43. Asia Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 44. Asia Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 45. Asia Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 46. Asia Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 47. Asia Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022) & (US$ Million)
  • Table 48. Asia Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028) & (US$ Million)
  • Table 49. Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 50. Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 51. Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 52. Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 53. Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 54. Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 55. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022) & (US$ Million)
  • Table 56. Middle East and Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028) & (US$ Million)
  • Table 57. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022) & (US$ Million)
  • Table 58. Middle East and Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028) & (US$ Million)
  • Table 59. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022) & (US$ Million)
  • Table 60. Middle East and Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028) & (US$ Million)
  • Table 61. AbbVie Company Details
  • Table 62. AbbVie Business Overview
  • Table 63. AbbVie Gastrointestinal Therapeutics Product
  • Table 64. AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 65. AbbVie Recent Developments
  • Table 66. Allergan Company Details
  • Table 67. Allergan Business Overview
  • Table 68. Allergan Gastrointestinal Therapeutics Product
  • Table 69. Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 70. Allergan Recent Developments
  • Table 71. Johnson & Johnson Company Details
  • Table 72. Johnson & Johnson Business Overview
  • Table 73. Johnson & Johnson Gastrointestinal Therapeutics Product
  • Table 74. Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 75. Johnson & Johnson Recent Developments
  • Table 76. Takeda Company Details
  • Table 77. Takeda Business Overview
  • Table 78. Takeda Gastrointestinal Therapeutics Product
  • Table 79. Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 80. Takeda Recent Developments
  • Table 81. Novartis Company Details
  • Table 82. Novartis Business Overview
  • Table 83. Novartis Gastrointestinal Therapeutics Product
  • Table 84. Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 85. Novartis Recent Developments
  • Table 86. Pfizer Company Details
  • Table 87. Pfizer Business Overview
  • Table 88. Pfizer Gastrointestinal Therapeutics Product
  • Table 89. Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 90. Pfizer Recent Developments
  • Table 91. Merck Company Details
  • Table 92. Merck Business Overview
  • Table 93. Merck Gastrointestinal Therapeutics Product
  • Table 94. Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 95. Merck Recent Developments
  • Table 96. F. Hoffmann-La Roche Company Details
  • Table 97. F. Hoffmann-La Roche Business Overview
  • Table 98. F. Hoffmann-La Roche Gastrointestinal Therapeutics Product
  • Table 99. F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 100. F. Hoffmann-La Roche Recent Developments
  • Table 101. Eli Lilly Company Details
  • Table 102. Eli Lilly Business Overview
  • Table 103. Eli Lilly Gastrointestinal Therapeutics Product
  • Table 104. Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 105. Eli Lilly Recent Developments
  • Table 106. AstraZeneca Company Details
  • Table 107. AstraZeneca Business Overview
  • Table 108. AstraZeneca Gastrointestinal Therapeutics Product
  • Table 109. AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 110. AstraZeneca Recent Developments
  • Table 111. Procter & Gamble Company Details
  • Table 112. Procter & Gamble Business Overview
  • Table 113. Procter & Gamble Gastrointestinal Therapeutics Product
  • Table 114. Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 115. Procter & Gamble Recent Developments
  • Table 116. Tillotts Pharma Company Details
  • Table 117. Tillotts Pharma Business Overview
  • Table 118. Tillotts Pharma Gastrointestinal Therapeutics Product
  • Table 119. Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 120. Tillotts Pharma Recent Developments
  • Table 121. Takeda Company Details
  • Table 122. Takeda Business Overview
  • Table 123. Takeda Gastrointestinal Therapeutics Product
  • Table 124. Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 125. Takeda Recent Developments
  • Table 126. GlaxoSmithKline Company Details
  • Table 127. GlaxoSmithKline Business Overview
  • Table 128. GlaxoSmithKline Gastrointestinal Therapeutics Product
  • Table 129. GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 130. GlaxoSmithKline Recent Developments
  • Table 131. Amgen Company Details
  • Table 132. Amgen Business Overview
  • Table 133. Amgen Gastrointestinal Therapeutics Product
  • Table 134. Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022) & (US$ Million)
  • Table 135. Amgen Recent Developments
  • Table 136. Research Programs/Design for This Report
  • Table 137. Key Data Information from Secondary Sources
  • Table 138. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Gastrointestinal Therapeutics Market Share by Type: 2021 VS 2028
  • Figure 2. Oral Features
  • Figure 3. Parenteral Features
  • Figure 4. Global Gastrointestinal Therapeutics Market Share by Application: 2021 VS 2028
  • Figure 5. IBD Case Studies
  • Figure 6. Irritable Bowel Syndrome (IBS) Case Studies
  • Figure 7. Gastrointestinal Therapeutics Report Years Considered
  • Figure 8. Global Gastrointestinal Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 9. Global Gastrointestinal Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 10. Global Gastrointestinal Therapeutics Market Share by Region: 2021 VS 2028
  • Figure 11. Global Gastrointestinal Therapeutics Market Share by Players in 2021
  • Figure 12. Global Top Gastrointestinal Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastrointestinal Therapeutics as of 2021)
  • Figure 13. The Top 10 and 5 Players Market Share by Gastrointestinal Therapeutics Revenue in 2021
  • Figure 14. North America Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 15. North America Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 16. North America Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 17. North America Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
  • Figure 18. United States Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 19. Canada Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 20. Europe Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 21. Europe Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 22. Europe Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 23. Europe Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
  • Figure 24. Germany Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 25. France Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 26. U.K. Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 27. Italy Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. Russia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. Nordic Countries Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Asia-Pacific Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 31. Asia Pacific Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 32. Asia Pacific Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 33. Asia Pacific Gastrointestinal Therapeutics Market Size Share by Region (2017-2028)
  • Figure 34. China Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 35. Japan Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. South Korea Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. Southeast Asia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. India Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. Australia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

  • Figure 40. Latin America Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 41. Latin America Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 42. Latin America Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 43. Latin America Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
  • Figure 44. Mexico Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. Brazil Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 46. Middle East & Africa Gastrointestinal Therapeutics Market Size YoY (2017-2028) & (US$ Million)
  • Figure 47. Middle East and Africa Gastrointestinal Therapeutics Market Size Market Share by Type (2017-2028)
  • Figure 48. Middle East and Africa Gastrointestinal Therapeutics Market Size Market Share by Application (2017-2028)
  • Figure 49. Middle East and Africa Gastrointestinal Therapeutics Market Size Share by Country (2017-2028)
  • Figure 50. Turkey Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 51. Saudi Arabia Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 52. UAE Gastrointestinal Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 53. AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 54. Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 55. Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 56. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 57. Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 58. Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 59. Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 60. F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 61. Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 62. AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 63. Procter & Gamble Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 64. Tillotts Pharma Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 65. Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 66. GlaxoSmithKline Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 67. Amgen Revenue Growth Rate in Gastrointestinal Therapeutics Business (2017-2022)
  • Figure 68. Bottom-up and Top-down Approaches for This Report
  • Figure 69. Data Triangulation
  • Figure 70. Key Executives Interviewed
目次

This research report focuses on the Gastrointestinal Therapeutics Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Business Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Oral
    • 1.2.3 Parenteral
  • 1.3 Market by Application
    • 1.3.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 IBD
    • 1.3.3 Irritable Bowel Syndrome (IBS)
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Gastrointestinal Therapeutics Market Perspective (2017-2028)
  • 2.2 Gastrointestinal Therapeutics Growth Trends by Region
    • 2.2.1 Gastrointestinal Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 Gastrointestinal Therapeutics Historic Market Size by Region (2017-2022)
    • 2.2.3 Gastrointestinal Therapeutics Forecasted Market Size by Region (2023-2028)
  • 2.3 Gastrointestinal Therapeutics Market Dynamics
    • 2.3.1 Gastrointestinal Therapeutics Industry Trends
    • 2.3.2 Gastrointestinal Therapeutics Market Drivers
    • 2.3.3 Gastrointestinal Therapeutics Market Challenges
    • 2.3.4 Gastrointestinal Therapeutics Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Gastrointestinal Therapeutics Players by Revenue
    • 3.1.1 Global Top Gastrointestinal Therapeutics Players by Revenue (2017-2022)
    • 3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Players (2017-2022)
  • 3.2 Global Gastrointestinal Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by Gastrointestinal Therapeutics Revenue
  • 3.4 Global Gastrointestinal Therapeutics Market Concentration Ratio
    • 3.4.1 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Gastrointestinal Therapeutics Revenue in 2021
  • 3.5 Gastrointestinal Therapeutics Key Players Head office and Area Served
  • 3.6 Key Players Gastrointestinal Therapeutics Product Solution and Service
  • 3.7 Date of Enter into Gastrointestinal Therapeutics Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Gastrointestinal Therapeutics Breakdown Data by Type

  • 4.1 Global Gastrointestinal Therapeutics Historic Market Size by Type (2017-2022)
  • 4.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Type (2023-2028)

5 Gastrointestinal Therapeutics Breakdown Data by Application

  • 5.1 Global Gastrointestinal Therapeutics Historic Market Size by Application (2017-2022)
  • 5.2 Global Gastrointestinal Therapeutics Forecasted Market Size by Application (2023-2028)

6 North America

  • 6.1 North America Gastrointestinal Therapeutics Market Size (2017-2028)
  • 6.2 North America Gastrointestinal Therapeutics Market Size by Type
    • 6.2.1 North America Gastrointestinal Therapeutics Market Size by Type (2017-2022)
    • 6.2.2 North America Gastrointestinal Therapeutics Market Size by Type (2023-2028)
    • 6.2.3 North America Gastrointestinal Therapeutics Market Share by Type (2017-2028)
  • 6.3 North America Gastrointestinal Therapeutics Market Size by Application
    • 6.3.1 North America Gastrointestinal Therapeutics Market Size by Application (2017-2022)
    • 6.3.2 North America Gastrointestinal Therapeutics Market Size by Application (2023-2028)
    • 6.3.3 North America Gastrointestinal Therapeutics Market Share by Application (2017-2028)
  • 6.4 North America Gastrointestinal Therapeutics Market Size by Country
    • 6.4.1 North America Gastrointestinal Therapeutics Market Size by Country (2017-2022)
    • 6.4.2 North America Gastrointestinal Therapeutics Market Size by Country (2023-2028)
    • 6.4.3 U.S.
    • 6.4.4 Canada

7 Europe

  • 7.1 Europe Gastrointestinal Therapeutics Market Size (2017-2028)
  • 7.2 Europe Gastrointestinal Therapeutics Market Size by Type
    • 7.2.1 Europe Gastrointestinal Therapeutics Market Size by Type (2017-2022)
    • 7.2.2 Europe Gastrointestinal Therapeutics Market Size by Type (2023-2028)
    • 7.2.3 Europe Gastrointestinal Therapeutics Market Share by Type (2017-2028)
  • 7.3 Europe Gastrointestinal Therapeutics Market Size by Application
    • 7.3.1 Europe Gastrointestinal Therapeutics Market Size by Application (2017-2022)
    • 7.3.2 Europe Gastrointestinal Therapeutics Market Size by Application (2023-2028)
    • 7.3.3 Europe Gastrointestinal Therapeutics Market Share by Application (2017-2028)
  • 7.4 Europe Gastrointestinal Therapeutics Market Size by Country
    • 7.4.1 Europe Gastrointestinal Therapeutics Market Size by Country (2017-2022)
    • 7.4.2 Europe Gastrointestinal Therapeutics Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 Asia-Pacific

  • 8.1 Asia-Pacific Gastrointestinal Therapeutics Market Size (2017-2028)
  • 8.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type
    • 8.2.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Type (2017-2028)
  • 8.3 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application
    • 8.3.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific Gastrointestinal Therapeutics Market Share by Application (2017-2028)
  • 8.4 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region
    • 8.4.1 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific Gastrointestinal Therapeutics Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 Southeast Asia
    • 8.4.7 India
    • 8.4.8 Australia

9 Latin America

  • 9.1 Latin America Gastrointestinal Therapeutics Market Size (2017-2028)
  • 9.2 Latin America Gastrointestinal Therapeutics Market Size by Type
    • 9.2.1 Latin America Gastrointestinal Therapeutics Market Size by Type (2017-2022)
    • 9.2.2 Latin America Gastrointestinal Therapeutics Market Size by Type (2023-2028)
    • 9.2.3 Latin America Gastrointestinal Therapeutics Market Share by Type (2017-2028)
  • 9.3 Latin America Gastrointestinal Therapeutics Market Size by Application
    • 9.3.1 Latin America Gastrointestinal Therapeutics Market Size by Application (2017-2022)
    • 9.3.2 Latin America Gastrointestinal Therapeutics Market Size by Application (2023-2028)
    • 9.3.3 Latin America Gastrointestinal Therapeutics Market Share by Application (2017-2028)
  • 9.4 Latin America Gastrointestinal Therapeutics Market Size by Country
    • 9.4.1 Latin America Gastrointestinal Therapeutics Market Size by Country (2017-2022)
    • 9.4.2 Latin America Gastrointestinal Therapeutics Market Size by Country (2023-2028)
    • 9.4.3 Mexico
    • 9.4.4 Brazil

10 Middle East & Africa

  • 10.1 Middle East & Africa Gastrointestinal Therapeutics Market Size (2017-2028)
  • 10.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type
    • 10.2.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Type (2017-2028)
  • 10.3 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application
    • 10.3.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa Gastrointestinal Therapeutics Market Share by Application (2017-2028)
  • 10.4 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country
    • 10.4.1 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa Gastrointestinal Therapeutics Market Size by Country (2023-2028)
    • 10.4.3 Turkey
    • 10.4.4 Saudi Arabia
    • 10.4.5 UAE

11 Key Players Profiles

  • 11.1 AbbVie
    • 11.1.1 AbbVie Company Details
    • 11.1.2 AbbVie Business Overview
    • 11.1.3 AbbVie Gastrointestinal Therapeutics Introduction
    • 11.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.1.5 AbbVie Recent Developments
  • 11.2 Allergan
    • 11.2.1 Allergan Company Details
    • 11.2.2 Allergan Business Overview
    • 11.2.3 Allergan Gastrointestinal Therapeutics Introduction
    • 11.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.2.5 Allergan Recent Developments
  • 11.3 Johnson & Johnson
    • 11.3.1 Johnson & Johnson Company Details
    • 11.3.2 Johnson & Johnson Business Overview
    • 11.3.3 Johnson & Johnson Gastrointestinal Therapeutics Introduction
    • 11.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.3.5 Johnson & Johnson Recent Developments
  • 11.4 Takeda
    • 11.4.1 Takeda Company Details
    • 11.4.2 Takeda Business Overview
    • 11.4.3 Takeda Gastrointestinal Therapeutics Introduction
    • 11.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.4.5 Takeda Recent Developments
  • 11.5 Novartis
    • 11.5.1 Novartis Company Details
    • 11.5.2 Novartis Business Overview
    • 11.5.3 Novartis Gastrointestinal Therapeutics Introduction
    • 11.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.5.5 Novartis Recent Developments
  • 11.6 Pfizer
    • 11.6.1 Pfizer Company Details
    • 11.6.2 Pfizer Business Overview
    • 11.6.3 Pfizer Gastrointestinal Therapeutics Introduction
    • 11.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.6.5 Pfizer Recent Developments
  • 11.7 Merck
    • 11.7.1 Merck Company Details
    • 11.7.2 Merck Business Overview
    • 11.7.3 Merck Gastrointestinal Therapeutics Introduction
    • 11.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.7.5 Merck Recent Developments
  • 11.8 F. Hoffmann-La Roche
    • 11.8.1 F. Hoffmann-La Roche Company Details
    • 11.8.2 F. Hoffmann-La Roche Business Overview
    • 11.8.3 F. Hoffmann-La Roche Gastrointestinal Therapeutics Introduction
    • 11.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.8.5 F. Hoffmann-La Roche Recent Developments
  • 11.9 Eli Lilly
    • 11.9.1 Eli Lilly Company Details
    • 11.9.2 Eli Lilly Business Overview
    • 11.9.3 Eli Lilly Gastrointestinal Therapeutics Introduction
    • 11.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.9.5 Eli Lilly Recent Developments
  • 11.10 AstraZeneca
    • 11.10.1 AstraZeneca Company Details
    • 11.10.2 AstraZeneca Business Overview
    • 11.10.3 AstraZeneca Gastrointestinal Therapeutics Introduction
    • 11.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.10.5 AstraZeneca Recent Developments
  • 11.11 Procter & Gamble
    • 11.11.1 Procter & Gamble Company Details
    • 11.11.2 Procter & Gamble Business Overview
    • 11.11.3 Procter & Gamble Gastrointestinal Therapeutics Introduction
    • 11.11.4 Procter & Gamble Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.11.5 Procter & Gamble Recent Developments
  • 11.12 Tillotts Pharma
    • 11.12.1 Tillotts Pharma Company Details
    • 11.12.2 Tillotts Pharma Business Overview
    • 11.12.3 Tillotts Pharma Gastrointestinal Therapeutics Introduction
    • 11.12.4 Tillotts Pharma Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.12.5 Tillotts Pharma Recent Developments
  • 11.13 Takeda
    • 11.13.1 Takeda Company Details
    • 11.13.2 Takeda Business Overview
    • 11.13.3 Takeda Gastrointestinal Therapeutics Introduction
    • 11.13.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.13.5 Takeda Recent Developments
  • 11.14 GlaxoSmithKline
    • 11.14.1 GlaxoSmithKline Company Details
    • 11.14.2 GlaxoSmithKline Business Overview
    • 11.14.3 GlaxoSmithKline Gastrointestinal Therapeutics Introduction
    • 11.14.4 GlaxoSmithKline Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.14.5 GlaxoSmithKline Recent Developments
  • 11.15 Amgen
    • 11.15.1 Amgen Company Details
    • 11.15.2 Amgen Business Overview
    • 11.15.3 Amgen Gastrointestinal Therapeutics Introduction
    • 11.15.4 Amgen Revenue in Gastrointestinal Therapeutics Business (2017-2022)
    • 11.15.5 Amgen Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Author Details
  • 13.3 Disclaimer